Market Update

Market Watch

Thursday, 26 November 2015

Live MCX Market Update with Bullion Tips



Gold hovered close to its lowest in nearly six years on Thursday.
           Spot gold was little changed at $1,071.96 an ounce by 0245 GMT, after dropping 0.4 percent on Wednesday.
           Gold had seen some safe-haven bids earlier in the week after Turkey downed a Russian fighter jet.
Perth Mint will work with ASX Ltd to develop precious metals derivatives that will be traded on the Australian exchange, the companies said on Thursday.
            The Sensex is up 97.50 points or 0.4 percent at 25873.24, and the Nifty is up 17.40 points or 0.2 percent at 7849. About 851 shares have advanced, 228 shares declined, and 72 shares are unchanged.
            Dr Reddy's Labs is down 8.5 percent while Hero, HDFC Bank, Wipro and Lupin are major losers. Sun Pharma, Tata Motors, Infosys, L&T and HUL are top gainers.
           The Indian rupee has opened marginally lower at 66.35 per dollar on Thursday against 66.32 a dollar in previous trading session.
               Asian shares advanced in early trade on Thursday, while growing bets the European Central Bank was gearing up to deliver further stimulus steps kept the euro under pressure.
            Shares of Hero MotoCorp were up 1.5 percent intraday. The US private equity firm Bain Capital will sell shares in Hero MotoCorp via block deal to raise as much as USD 116 million. Bain launched the deal to sell 2.98 million Hero shares in the indicative price band of between Rs 2,570 and Rs 2,600, says Reuters.
               In fresh trouble for Dr. Reddy's Laboratories (DRL), a warning letter has been uploaded on the US Food and Drug Administration website with regards to DRL's plants it had inspected recently. The administrator has identified significant deviations from current good manufacturing practices (CGMP) at three of DRL's plants. The three plants that were inspected earlier by US FDA were Unit VI of Srikakulam Plant, Unit V at Telangana’s Miryalaguda Taluk Plant and Unit VII at the Duvvada Plant in Visakhapatnam. The American regulator says it has identified significant deviations from CGMP at all three plants. For the plant units in Srikakulam and Miryalaguda the deviations lay for manufacturing active pharma ingredients (API's), while for the Oncology Plant at Duvvada, the problem lay with finished pharmaceutical products.

===================================================== Shares of Hero MotoCorp were up 1.5 percent intraday. The US private equity firm Bain Capital will sell shares in Hero MotoCorp via block deal to raise as much as USD 116 million. Bain launched the deal to sell 2.98 million Hero shares in the indicative price band of between Rs 2,570 and Rs 2,600, says Reuters. CapitalHeight provide customized services to our clients as per their requirements. For Accurate Mcx Gold, silver Tips & Market Update  Visit our site www.capitalheight.com/bullion-premium.php Call at 0731-6615050, 9993066624.

No comments:

Post a Comment